Bio-Techne (TECH) Gross Profit (2009 - 2026)

Bio-Techne's Gross Profit history runs 18 years deep, the most recent figure standing at $208.3 million for Q1 2026.

• On a quarterly basis, Gross Profit fell 2.92% year-over-year to $208.3 million in Q1 2026; TTM through Mar 2026 was $786.5 million, a 1.05% decrease from a year earlier, with the FY2025 full-year figure at $790.3 million, up 2.67% from the prior year.
• Gross Profit grew to $208.3 million in Q1 2026 per TECH's latest filing, from $191.3 million in the prior quarter.
• Across five years, Gross Profit topped out at $214.6 million in Q1 2025 and bottomed at $176.6 million in Q4 2023.
• The 5-year median for Gross Profit is $198.8 million (2025), against an average of $195.3 million.
• Across the five-year window, Gross Profit increased 19.72% in 2022 and fell 3.69% in 2023, its largest moves.
• Year by year, Gross Profit stood at $183.4 million in 2022, then fell by 3.69% to $176.6 million in 2023, then increased by 9.8% to $193.9 million in 2024, then declined by 1.35% to $191.3 million in 2025, then climbed by 8.89% to $208.3 million in 2026.
• Per Business Quant, the three latest TECH Gross Profit figures stand at $208.3 million (Q1 2026), $191.3 million (Q4 2025), and $188.1 million (Q3 2025).